Literature DB >> 18050270

Requirement of secondary lymphoid tissues for the induction of primary and secondary T cell responses against Listeria monocytogenes.

Mischo Kursar1, Nathalie Jänner, Klaus Pfeffer, Volker Brinkmann, Stefan H E Kaufmann, Hans-Willi Mittrücker.   

Abstract

Activation of naive T cells is tightly controlled and depends on cognate interactions with professional antigen-presenting cells. We analyzed dependency on secondary lymphoid tissues for the activation of naive and memory CD4(+) and CD8(+) T cells following primary and secondary Listeria monocytogenes infection, respectively. In splenectomized lymphotoxin-beta receptor-deficient mice, lacking all secondary lymphoid tissues, oral infection with L. monocytogenes failed to induce bacteria-specific CD4(+) and CD8(+) T cell responses. Treatment of splenectomized wild-type mice with FTY720, a drug that prevents egress of T cells from lymph nodes, also reduced T cell responses after oral L. monocytogenes infection and blocked T cell responses after intravenous infection. FTY720-treated wild-type and lymphotoxin-beta receptor-deficient mice show only slightly impaired recall responses. However, T cell responses were profoundly inhibited when mice were splenectomized subsequently to recovery from primary infection. T cell transfer experiments demonstrated that the impaired secondary T cell response was not simply due to removal of a large fraction of memory T cells by splenectomy. Overall, these results indicate that not only primary T cell responses, but also secondary T cell responses, highly depend on the lymphoid environment for effective activation.

Entities:  

Mesh:

Year:  2008        PMID: 18050270     DOI: 10.1002/eji.200737142

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

2.  Discovery of a Potent, S1P3-Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1).

Authors:  Brian A Lanman; Victor J Cee; Srinivasa R Cheruku; Mike Frohn; Jennifer Golden; Jian Lin; Mercedes Lobera; Yael Marantz; Kristine M Muller; Susana C Neira; Alexander J Pickrell; Dalia Rivenzon-Segal; Nili Schutz; Anurag Sharadendu; Xiang Yu; Zhaoda Zhang; Janet Buys; Mike Fiorino; Anu Gore; Michelle Horner; Andrea Itano; Michele McElvain; Scot Middleton; Michael Schrag; Hugo M Vargas; Han Xu; Yang Xu; Xuxia Zhang; Jerry Siu; Roland W Bürli
Journal:  ACS Med Chem Lett       Date:  2010-11-09       Impact factor: 4.345

Review 3.  FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.

Authors:  Volker Brinkmann
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

Review 4.  Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.

Authors:  Jerold Chun; Hans-Peter Hartung
Journal:  Clin Neuropharmacol       Date:  2010 Mar-Apr       Impact factor: 1.592

5.  The Lymphotoxin β Receptor Is Essential for Upregulation of IFN-Induced Guanylate-Binding Proteins and Survival after Toxoplasma gondii Infection.

Authors:  Kristina Behnke; Ursula R Sorg; Helmut E Gabbert; Klaus Pfeffer
Journal:  Mediators Inflamm       Date:  2017-08-06       Impact factor: 4.711

6.  Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination.

Authors:  José R Vasconcelos; Mariana R Dominguez; Adriano F Araújo; Jonatan Ersching; Cibele A Tararam; Oscar Bruna-Romero; Mauricio M Rodrigues
Journal:  Front Immunol       Date:  2012-12-04       Impact factor: 7.561

7.  The function of the chemokine receptor CXCR6 in the T cell response of mice against Listeria monocytogenes.

Authors:  Kira Heesch; Friederike Raczkowski; Valéa Schumacher; Stefanie Hünemörder; Ulf Panzer; Hans-Willi Mittrücker
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.